v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance, beginning of period (in shares) at Dec. 31, 2024   115,764,839      
Balance, beginning of period at Dec. 31, 2024 $ 387,222 $ 12 $ 467,076 $ (74,816) $ (5,050)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (5,962)     (5,962)  
Foreign currency translation adjustments 217       217
Issuance of common stock upon release of restricted stock units (in shares)   941,370      
Common stock withheld for taxes on restricted stock units (in shares)   (343,232)      
Common stock withheld for taxes on restricted stock units (2,306)   (2,306)    
Stock-based compensation expense 1,971   1,971    
Balance, end of period (in shares) at Mar. 29, 2025   116,362,977      
Balance, end of period at Mar. 29, 2025 381,142 $ 12 466,741 (80,778) (4,833)
Balance, beginning of period (in shares) at Dec. 31, 2025   116,766,927      
Balance, beginning of period at Dec. 31, 2025 405,861 $ 12 473,423 (63,692) (3,882)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (8,534)     (8,534)  
Foreign currency translation adjustments 653       653
Issuance of common stock upon release of restricted stock units (in shares)   1,005,086      
Common stock withheld for taxes on restricted stock units (in shares)   (364,294)      
Common stock withheld for taxes on restricted stock units (2,382)   (2,382)    
Stock-based compensation expense 1,104   1,104    
Balance, end of period (in shares) at Mar. 28, 2026   117,407,719      
Balance, end of period at Mar. 28, 2026 $ 396,702 $ 12 $ 472,145 $ (72,226) $ (3,229)